The Central Epidemic Command Center (CECC) said on Sunday it is considering purchasing an experimental pill that, according to its makers, significantly reduces the risk of hospitalization or death from COVID-19.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Foreign applicants for Taiwanese language test hit 5-year high
07/25/2026 06:57 PM - Business
CPC to raise domestic gasoline, diesel prices next week
07/25/2026 05:55 PM - Politics
KMT rallies candidates ahead of 2026 local elections
07/25/2026 04:45 PM - Society
Yunlin sheep meat with excessive dioxin levels kept off market: TFDA
07/25/2026 04:25 PM - Politics
Malaysian culinary contest removes Taiwan flag after teams win golds
07/25/2026 03:45 PM